Articles written by: Mike Johnson

Capricor Therapeutics Inc. (CAPR)’s Financial Results Comparing With Sage Therapeutics Inc. (NASDAQ:SAGE)

This is a contrast between Capricor Therapeutics Inc. (NASDAQ:CAPR) and Sage Therapeutics Inc. (NASDAQ:SAGE) based on their risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership. The two companies are Biotechnology and they also compete with each other. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Comparing of Immunomedics Inc. (IMMU) and OPKO Health Inc. (NASDAQ:OPK)

We are contrasting Immunomedics Inc. (NASDAQ:IMMU) and OPKO Health Inc. (NASDAQ:OPK) on their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. They both are Biotechnology companies, competing one another. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Immunomedics Inc. 15 -3699.65 N/A […]

Reviewing Fibrocell Science Inc. (FCSC)’s and Zoetis Inc. (NYSE:ZTS)’s results

This is therefore a contrasting of the dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation in Fibrocell Science Inc. (NASDAQ:FCSC) and Zoetis Inc. (NYSE:ZTS). The two are both Drugs – Generic companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Blueprint Medicines Corporation (BPMC) and Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Contrasting side by side

As Biotechnology businesses, Blueprint Medicines Corporation (NASDAQ:BPMC) and Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), are affected by contrast. This especially applies to their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Blueprint Medicines Corporation 85 […]

Comparison of Cornerstone Strategic Value Fund Inc. (CLM) and Nuveen California AMT-Free Quality Municipal Income Fund (NYSE:NKX)

Both Cornerstone Strategic Value Fund Inc. (NYSE:CLM) and Nuveen California AMT-Free Quality Municipal Income Fund (NYSE:NKX) compete on a level playing field in the Asset Management industry. We will evaluate their performance with regards to institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations. Valuation & Earnings Gross Revenue […]

Contrasting of Ritter Pharmaceuticals Inc. (RTTR) and Epizyme Inc. (NASDAQ:EPZM)

Both Ritter Pharmaceuticals Inc. (NASDAQ:RTTR) and Epizyme Inc. (NASDAQ:EPZM) are each other’s competitor in the Biotechnology industry. Thus the compare of their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ritter Pharmaceuticals Inc. 1 […]

Reviewing Landcadia Holdings II Inc. (LCAHU)’s and Trinity Merger Corp. (NASDAQ:TMCXU)’s results

Landcadia Holdings II Inc. (NASDAQ:LCAHU) and Trinity Merger Corp. (NASDAQ:TMCXU), both competing one another are Conglomerates companies. We will compare their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Landcadia Holdings II Inc. N/A […]

Reviewing Och-Ziff Capital Management Group Inc. (OZM)’s and Focus Financial Partners Inc. (NASDAQ:FOCS)’s results

As Asset Management companies, Och-Ziff Capital Management Group Inc. (NYSE:OZM) and Focus Financial Partners Inc. (NASDAQ:FOCS) are our subject to compare. And more specifically their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Och-Ziff […]